A dual dopaminergic therapy with L-3,4-dihydroxyphenylalanine and chlorpromazine for the treatment of blepharospasm, a focal dystonia: Possible implications for striosomal D1 signaling
Authors:
Open Access
- 25 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13
Abstract
Impairment of balanced activity between dopamine D1 and D2 receptor functions in the striatum, particularly in striatal functional subdivisions (i.e., striosome and matrix compartments), has been proposed to underlie dystonia genesis. This study was undertaken to examine the therapeutic effect of dual dopaminergic modulation with L-3,4-dihydroxyphenylalanine (L-DOPA) and chlorpromazine (CPZ) in patients with blepharospasm, a focal dystonia. For this purpose, Dopacol tablets™ (L-DOPA 50 mg plus carbidopa 5 mg) and Wintermin™ (CPZ phenolphthalinate 180 mg/g) were used. Clinical evaluations were performed before and after an 8-week drug treatment interval using the Visual Analog Scale (VAS), Blepharospasm Disability Index (BSDI), modified VAS (mVAS), and Jankovic Rating Scale (JRS). The data were analyzed using non-parametric statistics. Results showed that in patients (n = 7) with blepharospasm, dystonia symptoms were significantly alleviated by the administration of both Dopacol tablets™ (one tablet × 3/day) and CPZ (5 mg × 3/day), as determined using the VAS, BSDI, mVAS, and JRS. In contrast, there was no improvement of dystonia symptoms in patients (n = 7) who ingested Dopacol tablets™ (one tablet × 3/day) alone, nor in those (n = 7) who ingested CPZ (5 mg × 3/day) alone. Thus, dual pharmacotherapy with L-DOPA and CPZ can exert a therapeutic effect on blepharospasm, suggesting that dystonia symptoms can be attenuated through dopaminergic modulation with inducing an increase in striatal D1-signals. Since dopamine D1 receptors are heavily enriched in the striosome compartment in the “human” striatum, our results also suggest that striosomal loss of D1-signaling may be important in the pathogenesis of dystonia.Keywords
This publication has 49 references indexed in Scilit:
- Long-Term Efficacy and Safety of Botulinum Toxin Injections in DystoniaToxins, 2013
- Immunogenicity of botulinum toxinsJournal of Neural Transmission, 2012
- Shifting Responsibly: The Importance of Striatal Modularity to Reinforcement Learning in Uncertain EnvironmentsFrontiers in Human Neuroscience, 2011
- Basal Ganglia Disorders Associated with Imbalances in the Striatal Striosome and Matrix CompartmentsFrontiers in Neuroanatomy, 2011
- Identification of a Specific Assembly of the G Protein Golf as a Critical and Regulated Module of Dopamine and Adenosine-Activated cAMP Pathways in the StriatumFrontiers in Neuroanatomy, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Olfactory type G-protein α subunit in striosome-matrix dopamine systems in adult miceNeuroscience, 2010
- Essential BlepharospasmSeminars in Ophthalmology, 2010
- Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystoniaProceedings of the National Academy of Sciences, 2008
- Habits, Rituals, and the Evaluative BrainAnnual Review of Neuroscience, 2008